Human medicines European public assessment report (EPAR): Nepexto, etanercept, Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Spondylarthropathies;Spondylitis, Ankylosing;Psoriasis, Date of authorisation: 20/05/2020, Revision:

Submitted by Anonymous (not verified) on 7 September 2023 - 8:21

Human medicines European public assessment report (EPAR): Nepexto, etanercept, Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Spondylarthropathies;Spondylitis, Ankylosing;Psoriasis, Date of authorisation: 20/05/2020, Revision: 10, Status: Authorised

Link: 
https://www.ema.europa.eu/en/medicines/human/EPAR/nepexto
Source: 
What's new

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More